Page last updated: 2024-09-02

ecteinascidin 743 and Cancer, Second Primary

ecteinascidin 743 has been researched along with Cancer, Second Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Douer, D; Liu, SV; Tahbaz, A; Zneimer, S	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Cancer, Second Primary

Article	Year
Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma. Acta haematologica, 2011, Volume: 126, Issue:2 Topics: Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Dioxoles; Etoposide; Fatal Outcome; Female; Gene Deletion; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Sarcoma, Ewing; Tetrahydroisoquinolines; Topoisomerase Inhibitors; Trabectedin; Young Adult	2011

Article

Year

Acta haematologica, 2011, Volume: 126, Issue:2

Topics: Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Dioxoles; Etoposide; Fatal Outcome; Female; Gene Deletion; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Sarcoma, Ewing; Tetrahydroisoquinolines; Topoisomerase Inhibitors; Trabectedin; Young Adult

2011